2024-10-15T13:51:07-05:00 2023-12-31 060530830 SEWARD AND MONDE CPA'S 296 STATE STREET NORTH HAVEN CT 064732165 990 2023-01-01 060646780 THE JOHN B PIERCE LABORATORY INC JOHN 2035629901 290 CONGRESS AVENUE NEW HAVEN CT 06519 MARGARET P MASON PRESIDENT 2035629901 2024-09-19 1 1 GAYLE A CARBONE P01010777 2032489341 2023 2024-10-15 13:58:12Z MARGARET P MASON 290 CONGRESS AVENUE NEW HAVEN CT 06519 4712811 0 X JBPIERCE.ORG X 1934 CT TO CONDUCT BASIC RESEARCH ON THE INTERACTIONS BETWEEN PHYSIOLOGICAL SYSTEMS AND THE STRESSES IMPOSED BY THE MODERN ENVIRONMENT WITH THE GOAL OF OPTIMIZING THESE INTERACTIONS TO IMPROVE HUMAN HEALTH AND COMFORT. 5 5 29 0 0 0 4032286 4258376 0 0 491737 -38315 300842 454435 4824865 4674496 655897 258905 0 0 3577081 3191828 0 0 0 1217441 1117809 5450419 4568542 -625554 105954 6496534 5332394 2615584 1345490 3880950 3986904 X TO CONDUCT BASIC RESEARCH ON THE INTERACTIONS BETWEEN PHYSIOLOGICAL SYSTEMS AND THE STRESSES IMPOSED BY THE MODERN ENVIRONMENT WITH THE GOAL OF OPTIMIZING THESE INTERACTIONS TO IMPROVE HUMAN HEALTH AND COMFORT. 0 0 2604101 258905 JOHN B. PIERCE LABORATORY, FOUNDED IN 1933, AFFORDS A UNIQUE ENVIRONMENT FOR INTERACTION AND COLLABORATION AMONG SCIENTISTS WITHIN THE LABORATORY AND IN THE SURROUNDING YALE COMMUNITY. COLLABORATIONS THAT REACH ACROSS SUCH WIDE-RANGING FIELDS AS REGULATORY PHYSIOLOGY, SENSORY AND BEHAVIORAL NEUROSCIENCE, BRAIN IMAGING, MOLECULAR BIOLOGY AND GENETICS PLACE PIERCE LABORATORY SCIENTISTS IN A UNIQUE POSITION TO MAKE BREAKTHROUGHS IN BASIC RESEARCH THAT CAN BE TRANSLATED INTO IMPROVEMENTS IN HUMAN HEALTH AND WELL-BEING. WE CURRENTLY HAVE EIGHT GRANTS ONGOING INCLUDING: THE STUDY OF TOBACCO PRODUCT USE AND ADDICTION THROUGH FLAVORS, NICOTINE AND OTHER CONSTITUENTS; BIOLUMINESCENCE INTERFACE FOR AN ALL-OPTICAL NEUROPROSTHESIS TO THE VISUAL CORTEX; CARDIOMETABOLIC EFFECTS OF GENDER AFFIRMING HORMONE THERAPY; THE STUDY OF MECHANISMS OF HYPERTENSION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME; MECHANISMS AND INTERVENTIONS ADDRESSING ACCELERATED CARDIOVASCULAR DISEASE RISK IN WOMEN WITH ENDOMETRIOSIS; MAGNETIC, OPTICAL AND ACCOUSTIC NEURAL ACCESS DEVICE; THE PRINCIPLES OF OLFACTORY-GUIDED NATURAL BEHAVIOR; EFFICIENT TWO-PHOTON VOLTAGE IMAGING OF NEURONAL POPULATIONS AT BEHAVIORAL TIMESCALES. 2604101 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 17 0 1 29 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 X MICHELE SOLOMON 2035629901 290 CONGRESS AVENUE NEW HAVEN CT 06519 ANTHONY SCILLIA VICE PRESIDENT & DIRECTOR 2.00 2.00 X X 6966 0 0 MARGARET P MASON PRESIDENT & DIRECTOR 2.00 4.00 X X 13932 13932 0 KEVIN MYATT VICE PRESIDENT & DIRECTOR 2.00 2.00 X X 6966 0 0 GEOFFREY ETHERINGTON TREASURER & DIRECTOR 2.00 2.00 X X 6966 0 0 WILLIAM GINSBERG SECRETARY & DIRECTOR 2.00 2.00 X X 6966 0 0 JOHN GEIBEL DIRECTOR OF THE LAB 40.00 3.00 X 346250 0 51415 MICHELE SOLOMON DIRECTOR OF OPERATIONS 40.00 4.00 X 167761 0 30670 VINCENT PIERIBONE FELLOW 40.00 X 171418 0 47517 CHRIS VENDOLA DIRECTOR OF FACILITIES 40.00 2.00 X 150645 0 13386 NINA STACHENFELD FELLOW 40.00 X 150928 0 36223 JUSTUS VERHAGEN FELLOW 40.00 X 145972 0 35867 JOHN BUCKLEY DIRECTOR OF TECHNICAL SUPPORT SERVICES 40.00 X 143253 0 45123 1318023 13932 260201 7 0 1 0 KINSLEY POWER SYSTEMS DEPARTMENT 2150 PO BOX 986500 BOSTON MA 022986500 ENERGY SOLUTIONS PROVIDER 140710 1 2536173 1722203 4258376 336000 0 336000 336000 336000 38315 -38315 -38315 -38315 MISCELLANEOUS INCOME 541700 118435 118435 118435 4674496 454435 0 -38315 257025 257025 1880 1880 637892 637892 1811780 945706 866074 134758 70737 64021 437589 190723 246866 169809 67843 101966 49622 49622 30429 30429 10508 10508 48306 6190 42116 337023 2325 334698 18164 18164 29026 29026 395263 278729 116534 59938 59938 LABORATORY SUPPLIES & E 96200 60813 35387 ALLOC INDIRECT RESEARCH 0 676915 -676915 43330 27051 16279 4568542 2604101 1964441 0 254032 460393 1961755 653684 67665 197508 60714 83834 10146584 6209609 4152368 3936975 6496534 5332394 501716 294979 1411812 411580 702056 638931 2615584 1345490 X 3880950 3986904 3880950 3986904 6496534 5332394 105954 0 X 0 1 X 1 1 1 X 8887813 5800563 5890656 4032286 4258376 28869694 8887813 5800563 5890656 4032286 4258376 28869694 3057566 25812128 10080 4289 2607 187918 336000 540894 5376 24220 81033 113334 118435 342398 29752986 0.86750 0.86750 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2019 AMOUNT: $ 5,376. 2020 AMOUNT: $ 24,220. 2021 AMOUNT: $ 81,033. 2022 AMOUNT: $ 113,334. 2023 AMOUNT: $ 118,435. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 61359 61359 6944618 3647118 3297500 3127585 2551303 576282 13022 11188 1834 3936975 X 4712811 0 4712811 -38315 -38315 4674496 4606857 38315 38315 4568542 0 4568542 PART X, LINE 2: THE LABORATORY EVALUATES ALL SIGNIFICANT TAX POSITIONS AS REQUIRED BY ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA. AS OF DECEMBER 31, 2023, THE LABORATORY DOES NOT BELIEVE THAT IT HAS TAKEN ANY POSITIONS THAT WOULD REQUIRE THE RECORDING OF ANY ADDITIONAL TAX LIABILITY NOR DOES IT BELIEVE THAT THERE ARE ANY UNREALIZED TAX BENEFITS THAT WOULD EITHER INCREASE OR DECREASE WITHIN THE NEXT YEAR. IT IS THE LABORATORY'S POLICY TO RECOGNIZE ANY INTEREST AND PENALTIES IN THE PROVISION FOR TAXES. PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL -38,315. PART XII, LINE 2D - OTHER ADJUSTMENTS: LOSS ON DISPOSAL 38,315. 1 COLUMBIA UNIVERSITY 116TH AND BROADWAY NEW YORK NY 10027 135598093 501(C)(3) 244592 0 RESEARCH PROJECTS ON IBIS: IMPLANTABLE BIOLUMINESCENCE INTERFACE SYSTEM FOR AN ALL-OPTICAL NEUROPROSTHESIS TO THE VISUAL CORTEX PHASE II & PHASE III YALE UNIVERSITY 47 COLLEGE STREET NEW HAVEN CT 06510 060646973 501(C)(3) 19027 0 RESEARCH PROJECTS ON MECHANISMS AND INTERVENTIONS ADDRESSING ACCELERATED CARDIOVASCULAR DISEASE RISK IN WOMEN WITH ENDOMETRIOSIS 2 PART I, LINE 2: THE ORGANIZATION PERFORMS RIGOROUS MONITORING OF GRANTS. THE MONITORING PROCESS INCLUDES PRODUCTION OF MONTHLY STATEMENTS OF ALL RELATED ACTIVITY WHICH ARE THEN REVIEWED BY ADMINISTRATION AND THE INDIVIDUAL INVESTIGATORS. X X 0 0 0 0 0 0 0 0 0 JOHN GEIBEL DIRECTOR OF THE LAB 346250 0 0 0 0 0 28050 0 23365 0 397665 0 0 0 VINCENT PIERIBONE FELLOW 171418 0 0 0 0 0 14505 0 33012 0 218935 0 0 0 MICHELE SOLOMON DIRECTOR OF OPERATIONS 167761 0 0 0 0 0 14246 0 16424 0 198431 0 0 0 JOHN BUCKLEY DIRECTOR OF TECHNICAL SUPPORT SERVIC 143253 0 0 0 0 0 12111 0 33012 0 188376 0 0 0 NINA STACHENFELD FELLOW 150928 0 0 0 0 0 12728 0 23495 0 187151 0 0 0 JUSTUS VERHAGEN FELLOW 145972 0 0 0 0 0 12372 0 23495 0 181839 0 0 0 CHRIS VENDOLA DIRECTOR OF FACILITIES 150645 0 0 0 0 0 12770 0 616 0 164031 0 0 0 FORM 990, PART VI, SECTION A, LINE 8B THERE ARE NO OTHER COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B THE RETURN IS PROVIDED TO THE BOARD OF DIRECTORS FOR THEIR REVIEW PRIOR TO FILING. PRIOR TO THIS, THE RETURN IS ALSO REVIEWED BY THE BUSINESS MANAGER. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST STATEMENT IS SIGNED OFF BY EACH DIRECTOR AND EMPLOYEE ANNUALLY. EACH SUBMITTED DOCUMENT IS REVIEWED BY THE DIRECTOR. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION OF THE OFFICERS OF THE ORGANIZATION IS APPROVED BY THE BOARD OF DIRECTORS ANNUALLY. PERIODICALLY, COMPARABLES FOR SIMILARLY SITUATED INDIVIDUALS ARE REFERRED TO IN THE PROCESS. THIS PROCESS IS CONTEMPORANEOUSLY DOCUMENTED. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. THE JOHN B PIERCE FOUNDATION 290 CONGRESS AVENUE NEW HAVEN CT 06519 131624063 SECTION 509(A) SUPPORTING ORGANIZATION CT 501(C)(3) LINE 12B, II 0 NEW HAVEN INNOVATION LABS INC 290 CONGRESS AVENUE NEW HAVEN CT 06519 873267187 PROMOTE & SUPPORT ECONOMIC GROWTH IN CITY OF NEW HAVEN AND SCIENCE COMMUNITY CT 501(C)(3) LINE 10 THE JOHN B PIERCE LABORATORY INC 1 1 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 THE JOHN B PIERCE FOUNDATION C 1985000 CASH NEW HAVEN INNOVATION LABS INC C 551173 CASH NEW HAVEN INNOVATION LABS INC A 336000 CASH